Skeletal muscle hypertrophy rewires glucose metabolism: An experimental investigation and systematic review.
Warburg effect
lactate
metabolomics
resistance exercise
serine synthesis pathway
Journal
Journal of cachexia, sarcopenia and muscle
ISSN: 2190-6009
Titre abrégé: J Cachexia Sarcopenia Muscle
Pays: Germany
ID NLM: 101552883
Informations de publication
Date de publication:
14 May 2024
14 May 2024
Historique:
revised:
06
02
2024
received:
23
12
2022
accepted:
15
03
2024
medline:
14
5
2024
pubmed:
14
5
2024
entrez:
14
5
2024
Statut:
aheadofprint
Résumé
Proliferating cancer cells shift their metabolism towards glycolysis, even in the presence of oxygen, to especially generate glycolytic intermediates as substrates for anabolic reactions. We hypothesize that a similar metabolic remodelling occurs during skeletal muscle hypertrophy. We used mass spectrometry in hypertrophying C2C12 myotubes in vitro and plantaris mouse muscle in vivo and assessed metabolomic changes and the incorporation of the [U- The metabolomics analysis in myotubes revealed insulin-like growth factor-1 (IGF-1)-induced altered metabolite concentrations in anabolic pathways such as pentose phosphate (ribose-5-phosphate/ribulose-5-phosphate: +40%; P = 0.01) and serine synthesis pathway (serine: -36.8%; P = 0.009). Like the hypertrophy stimulation with IGF-1 in myotubes in vitro, the concentration of the dipeptide l-carnosine was decreased by 26.6% (P = 0.001) during skeletal muscle growth in vivo. However, phosphorylated sugar (glucose-6-phosphate, fructose-6-phosphate or glucose-1-phosphate) decreased by 32.2% (P = 0.004) in the overloaded muscle in vivo while increasing in the IGF-1-stimulated myotubes in vitro. The systematic review revealed that 10 metabolites linked to muscle hypertrophy were directly associated with glycolysis and its interconnected anabolic pathways. We demonstrated that labelled carbon from [U- Understanding the mechanisms that regulate skeletal muscle mass will help in developing effective treatments for muscle weakness. Our results provide evidence for the metabolic rewiring of glycolytic intermediates into anabolic pathways during muscle growth, such as in serine synthesis.
Sections du résumé
BACKGROUND
BACKGROUND
Proliferating cancer cells shift their metabolism towards glycolysis, even in the presence of oxygen, to especially generate glycolytic intermediates as substrates for anabolic reactions. We hypothesize that a similar metabolic remodelling occurs during skeletal muscle hypertrophy.
METHODS
METHODS
We used mass spectrometry in hypertrophying C2C12 myotubes in vitro and plantaris mouse muscle in vivo and assessed metabolomic changes and the incorporation of the [U-
RESULTS
RESULTS
The metabolomics analysis in myotubes revealed insulin-like growth factor-1 (IGF-1)-induced altered metabolite concentrations in anabolic pathways such as pentose phosphate (ribose-5-phosphate/ribulose-5-phosphate: +40%; P = 0.01) and serine synthesis pathway (serine: -36.8%; P = 0.009). Like the hypertrophy stimulation with IGF-1 in myotubes in vitro, the concentration of the dipeptide l-carnosine was decreased by 26.6% (P = 0.001) during skeletal muscle growth in vivo. However, phosphorylated sugar (glucose-6-phosphate, fructose-6-phosphate or glucose-1-phosphate) decreased by 32.2% (P = 0.004) in the overloaded muscle in vivo while increasing in the IGF-1-stimulated myotubes in vitro. The systematic review revealed that 10 metabolites linked to muscle hypertrophy were directly associated with glycolysis and its interconnected anabolic pathways. We demonstrated that labelled carbon from [U-
CONCLUSIONS
CONCLUSIONS
Understanding the mechanisms that regulate skeletal muscle mass will help in developing effective treatments for muscle weakness. Our results provide evidence for the metabolic rewiring of glycolytic intermediates into anabolic pathways during muscle growth, such as in serine synthesis.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : European Commission
ID : 754462
Organisme : TUM University Foundation Fellowship
Organisme : Company of Biologists Travelling Fellowship
Organisme : University of Jyväskylä (JYU) Visiting Fellow Program
Organisme : Deutsche Diabetes Stiftung
Informations de copyright
© 2024 The Authors. Journal of Cachexia, Sarcopenia and Muscle published by Wiley Periodicals LLC.
Références
Wackerhage H, Schoenfeld BJ, Hamilton DL, Lehti M, Hulmi JJ. Stimuli and sensors that initiate skeletal muscle hypertrophy following resistance exercise. J Appl Physiol 2019;126:30–43.
Colberg SR, Sigal RJ, Yardley JE, Riddell MC, Dunstan DW, Dempsey PC, et al. Physical activity/exercise and diabetes: a position statement of the American Diabetes Association. Diabetes Care 2016;39:2065–2079.
Goodman CA. Role of mTORC1 in mechanically induced increases in translation and skeletal muscle mass. J Appl Physiol 2019;127:581–590.
Koopman R, Ly CH, Ryall JG. A metabolic link to skeletal muscle wasting and regeneration. Front Physiol 2014;5:32.
Lunt SY, Vander Heiden MG. Aerobic glycolysis: meeting the metabolic requirements of cell proliferation. Annu Rev Cell Dev Biol 2011;27:441–464.
Hosios AM, Hecht VC, Danai LV, Johnson MO, Rathmell JC, Steinhauser ML, et al. Amino acids rather than glucose account for the majority of cell mass in proliferating mammalian cells. Dev Cell 2016;36:540–549.
Possemato R, Marks KM, Shaul YD, Pacold ME, Kim D, Birsoy K, et al. Functional genomics reveal that the serine synthesis pathway is essential in breast cancer. Nature 2011;476:346–350.
Stincone A, Prigione A, Cramer T, Wamelink MM, Campbell K, Cheung E, et al. The return of metabolism: biochemistry and physiology of the pentose phosphate pathway. Biol Rev 2015;90:927–963.
Locasale JW, Grassian AR, Melman T, Lyssiotis CA, Mattaini KR, Bass AJ, et al. Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis. Nat Genet 2011;43:869–874.
Wackerhage H, Vechetti IJ, Baumert P, Gehlert S, Becker L, Jaspers RT, et al. Does a hypertrophying muscle fibre reprogramme its metabolism similar to a cancer cell? Sports Med (Auckland, NZ) 2022;52:2569–2578.
Brown DM, Williams H, Ryan K, Wilson T, Daniel ZC, Mareko M, et al. Mitochondrial phosphoenolpyruvate carboxykinase (PEPCK‐M) and serine biosynthetic pathway genes are co‐ordinately increased during anabolic agent‐induced skeletal muscle growth. Sci Rep 2016;6:28693.
Valentino T, Figueiredo VC, Mobley CB, McCarthy JJ, Vechetti IJ Jr. Evidence of myomiR regulation of the pentose phosphate pathway during mechanical load‐induced hypertrophy. Physiol Rep 2021;9:e15137.
Hoshino D, Kawata K, Kunida K, Hatano A, Yugi K, Wada T, et al. Trans‐omic analysis reveals ROS‐dependent pentose phosphate pathway activation after high‐frequency electrical stimulation in C2C12 myotubes. iScience 2020;23:101558.
Cheng KK, Akasaki Y, Lecommandeur E, Lindsay RT, Murfitt S, Walsh K, et al. Metabolomic analysis of akt1‐mediated muscle hypertrophy in models of diet‐induced obesity and age‐related fat accumulation. J Proteome Res 2015;14:342–352.
Koh J‐H, Pataky MW, Dasari S, Klaus KA, Vuckovic I, Ruegsegger GN, et al. Enhancement of anaerobic glycolysis—a role of PGC‐1α4 in resistance exercise. Nat Commun 2022;13:2324.
Stadhouders LEM, Smith JAB, Gabriel BM, Verbrugge SAJ, Hammersen TD, Kolijn D, et al. Myotube growth is associated with cancer‐like metabolic reprogramming and is limited by phosphoglycerate dehydrogenase. Exp Cell Res 2023;113820.
Mäntyselkä S, Kolari K, Baumert P, Ylä‐Outinen L, Kuikka L, Lahtonen S, et al. Serine synthesis pathway enzyme PHGDH is critical for muscle cell biomass, anabolic metabolism, and mTORC1 signaling. Am J Physiol Endocrinol Metab 2024;326:E73–e91.
Romero‐Calvo I, Ocón B, Martínez‐Moya P, Suárez MD, Zarzuelo A, Martínez‐Augustin O, et al. Reversible Ponceau staining as a loading control alternative to actin in Western blots. Anal Biochem 2010;401:318–320.
Yuan M, Breitkopf SB, Yang X, Asara JM. A positive/negative ion–switching, targeted mass spectrometry–based metabolomics platform for bodily fluids, cells, and fresh and fixed tissue. Nat Protoc 2012;7:872–881.
Mountjoy E, Schmidt EM, Carmona M, Schwartzentruber J, Peat G, Miranda A, et al. An open approach to systematically prioritize causal variants and genes at all published human GWAS trait‐associated loci. Nat Genet 2021;53:1527–1533.
Pei Y‐F, Liu Y‐Z, Yang X‐L, Zhang H, Feng G‐J, Wei X‐T, et al. The genetic architecture of appendicular lean mass characterized by association analysis in the UK Biobank study. Commun Biol 2020;3:608.
Sudlow C, Gallacher J, Allen N, Beral V, Burton P, Danesh J, et al. UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med 2015;12:e1001779.
Consortium G. Genetic effects on gene expression across human tissues. Nature 2017;550:204–213.
Gheller BJ, Blum JE, Lim EW, Handzlik MK, Hannah Fong EH, Ko AC, et al. Extracellular serine and glycine are required for mouse and human skeletal muscle stem and progenitor cell function. Mol Metab 2021;43:101106.
Buescher JM, Antoniewicz MR, Boros LG, Burgess SC, Brunengraber H, Clish CB, et al. A roadmap for interpreting 13C metabolite labeling patterns from cells. Curr Opin Biotechnol 2015;34:189–201.
Amelio I, Cutruzzolá F, Antonov A, Agostini M, Melino G. Serine and glycine metabolism in cancer. Trends Biochem Sci 2014;39:191–198.
Lambert M, Bastide B, Cieniewski‐Bernard C. Involvement of O‐GlcNAcylation in the skeletal muscle physiology and physiopathology: focus on muscle metabolism. Front Endocrinol (Lausanne) 2018;9:9.
Weyrauch LA, McMillin SL, Witczak CA. Insulin resistance does not impair mechanical overload‐stimulated glucose uptake, but does alter the metabolic fate of glucose in mouse muscle. Int J Mol Sci 2020;21:4715.
Degens H, Meessen N, Wirtz P, Binkhorst R. The development of compensatory hypertrophy in the plantaris muscle of the rat. Ann Anatomy‐Anatomischer Anzeiger 1995;177:285–289.
Ajime TT, Serré J, Wüst RC, Burniston JG, Maes K, Janssens W, et al. The combination of smoking with vitamin D deficiency impairs skeletal muscle fiber hypertrophy in response to overload in mice. J Appl Physiol 2021;131:339–351.
Nielsen J, Oliver S. The next wave in metabolome analysis. Trends Biotechnol 2005;23:544–546.
Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta‐analysis protocols (PRISMA‐P) 2015 statement. Syst Rev 2015;4:1.
Collins‐Hooper H, Sartori R, Giallourou N, Matsakas A, Mitchell R, Makarenkova HP, et al. Symmorphosis through dietary regulation: a combinatorial role for proteolysis, autophagy and protein synthesis in normalising muscle metabolism and function of hypertrophic mice after acute starvation. PLoS ONE 2015;10:e0120524.
Khodabukus A, Madden L, Prabhu NK, Koves TR, Jackman CP, Muoio DM, et al. Electrical stimulation increases hypertrophy and metabolic flux in tissue‐engineered human skeletal muscle. Biomaterials 2019;198:259–269.
Wu C‐L, Satomi Y, Walsh K. RNA‐seq and metabolomic analyses of Akt1‐mediated muscle growth reveals regulation of regenerative pathways and changes in the muscle secretome. BMC Genomics 2017;18:181.
Fazelzadeh P, Hangelbroek RW, Tieland M, de Groot LC, Verdijk LB, Van Loon LJ, et al. The muscle metabolome differs between healthy and frail older adults. J Proteome Res 2016;15:499–509.
Turner DC, Gorski PP, Seaborne RA, Viggars M, Murphy M, Jarvis JC, et al. Mechanical loading of bioengineered skeletal muscle in vitro recapitulates gene expression signatures of resistance exercise in vivo. J Cell Physiol 2021;236:6534–6547.
Gehlert S, Weinisch P, Römisch‐Margl W, Jaspers RT, Artati A, Adamski J, et al. Effects of acute and chronic resistance exercise on the skeletal muscle metabolome. Metabolites 2022;12:445.
Lautaoja JH, O'Connell TM, Mäntyselkä S, Peräkylä J, Kainulainen H, Pekkala S, et al. Higher glucose availability augments the metabolic responses of the C2C12 myotubes to exercise‐like electrical pulse stimulation. Am J Physiol Endocrinol Metab 2021;321:E229–E245.
von Haehling S, Morley JE, Coats AJS, Anker SD. Ethical guidelines for publishing in the Journal of Cachexia, Sarcopenia and Muscle: update 2021. J Cachexia Sarcopenia Muscle 2021;12:2259–2261.